Results 141 to 150 of about 755 (183)
Some of the next articles are maybe not open access.
Intrauterine Devices: Medicated and Nonmedicated
International Journal of Gynecology and Obstetrics, 1979The main benefits of intrauterine devices (IUDs) are a lack of adverse systemic effects, excellent effectiveness, high continuation rates and the single act of motivation required for use. First year failure rates range from 2% to 3%, but decline steadily thereafter to a cumulative annual failure rate of less than 1% after six years.
D R Mishell
exaly +3 more sources
Medicated intrauterine devices for contraception and their therapeutic effects
Expert Review of Obstetrics and Gynecology, 2006There is currently one medicated intrauterine device on the market for clinical use; Mirena®, which releases levonorgestel. Mirena has widely replaced Progestasert®, which released progesterone. The levonorgestel released by Mirena into the uterine cavity not only increases the contraceptive efficacy of the intrauterine device but also has many ...
Tapani Luukkainen, Päivi Pakarinen
exaly +2 more sources
Fertility and Sterility, 1979
A comparative study of the Progestasert (UPS) and the Nova-T in 326 randomly selected women was carried out. The observation period was 1 year. The over-all continuation rates for the two types of intrauterine devices (IUDs) were similar. The expulsion rate for the Nova-T (9.2%) was considerably higher (P = 0.001) than that for the UPS (1.2%).
P, Fylling, M, Fagerhol
exaly +3 more sources
A comparative study of the Progestasert (UPS) and the Nova-T in 326 randomly selected women was carried out. The observation period was 1 year. The over-all continuation rates for the two types of intrauterine devices (IUDs) were similar. The expulsion rate for the Nova-T (9.2%) was considerably higher (P = 0.001) than that for the UPS (1.2%).
P, Fylling, M, Fagerhol
exaly +3 more sources
Medicated intrauterine devices. Physiological and clinical aspects
European Journal of Obstetrics, Gynecology and Reproductive Biology, 1983P Defoort
exaly +2 more sources
Medicated Intrauterine Devices to Improve Bleeding Events
International Journal of Gynecology & Obstetrics, 1977ABSTRACTIn an attempt to find an IUD that will cause a minimum amount of blood loss, while continuing to be effective and easily retained, we are studying 4 medicated IUDs: a copper‐bearing Lippes Loop, a Copper‐T‐200, a progesterone‐releasing U‐coil, and a tranexamic‐acid‐releasing Lippes Loop.
F, Hefnawi +4 more
openaire +2 more sources
Intrauterine device insertion after medical abortion
Contraception, 2011Studies comparing immediate intrauterine device (IUD) insertion after first-trimester surgical abortion with interval insertion show similar efficacy and expulsion rates. However, women randomized to interval insertion of an IUD are less likely to return for device placement.
Sarah J, Betstadt +4 more
openaire +2 more sources
A novel medical device for removal of intrauterine devices under direct vision
Contraception, 2012Evaluation of the efficacy of a novel medical device for removal of retained intrauterine devices (IUDs) under direct vision without uterine distention is reported.The five cases presented used the novel medical device to remove the IUDs. One woman had an incarcerated IUD, two women had fractured IUDs and two women had IUDs with lost threads.
Shili, Su +3 more
openaire +2 more sources
Gynecologic and Obstetric Investigation, 2008
<i>Aim:</i> To determine the effect of a copper-medicated intrauterine device (IUD) on ovarian, uterine, arcuate, radial and subendometrial Doppler-derived indices of blood flow. <i>Method:</i> 23 regularly menstruating patients requested insertion of an IUD.
O, Shen +4 more
openaire +2 more sources
<i>Aim:</i> To determine the effect of a copper-medicated intrauterine device (IUD) on ovarian, uterine, arcuate, radial and subendometrial Doppler-derived indices of blood flow. <i>Method:</i> 23 regularly menstruating patients requested insertion of an IUD.
O, Shen +4 more
openaire +2 more sources